Close
Help
Login
Staff Login
Register
0
Selected
Invert selection
Deselect all
Deselect all
Add to Cart
Click here to refresh results
Click here to refresh results
Go to Login page
Nova Scotia to expand use of Oxford-AstraZeneca vaccine to those 55-64
Nova Scotia to expand use of Oxford-AstraZeneca vaccine to those 55-64
Nova Scotia to expand use of Oxford-AstraZeneca vaccine to those 55-64
Standard Video
Actions
Overview
Conceptually Similar Documents
CP123262421 | N.S. pauses use of AstraZeneca vaccine
CP119781421 | N.S. to start administering AstraZeneca vaccines
CP122830710 | New Brunswick reports blood clot death in connection with Oxford-AstraZeneca vaccine
CP120852971 | Oxford-AstraZeneca suspension doesn't mean vaccine is unsafe: N.S. top doctor
CP120474321 | Nova Scotia's vaccine plan aims to vaccinate residents by end of June
CP122404571 | Quebec reports first blood clot death in woman who received AstraZeneca vaccine
CP121911021 | B.C. expands restrictions, AstraZeneca vaccine
CP21232617 | Nova Scotia reveals COVID-19 vaccine rollout
CP120476771 | AstraZeneca vaccine's benefits vastly outweigh risks: Sharma
CP112433171 | COVID case numbers relatively stable but N.S. medical officer says too early to relax
City
Vaughan
Country
Canada
Add to cart
Select usage
Type of video?
For editorial use only. Video needs to be used in its entirety (i.e. use of select segment(s) not allowed).
Audience Size
Usage description
Add to collection
Add to cart
Nova Scotia to expand use of Oxford-AstraZeneca vaccine to those 55-64
Source name:
The Canadian Press
Unique identifier:
CP120960271
Legacy Identifier:
n_NS-Vaccine-Update20210401T1430
Type:
Video
Duration:
1m50s
Dimensions:
1920px × 1080px 125.50 MB
Usage rights:
FOR ONE TIME USE ONLY. NO STORAGE FOR FUTURE USE.
Create Date:
4/1/2021 2:30:00 PM
Display aspect ratio:
16:9
Tags
COVID-19
Nova Scotia
vaccines